查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198707

子宮操縱器設備市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Uterine Manipulation Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

子宮操縱器設備市場預計在 2022-2027 年研究期間的複合年增長率為 5.8%。

由於 SARS-CoV-2 的高傳播性，COVID-19 大流行轉移了資源來照顧 COVID-19 患者，影響了非 COVID-19 醫療保健服務，並已成為全球醫療保健的挑戰中國的供應商，也正在影響子宮操縱器設備市場。 例如，根據 2021 年 10 月發表的一項研究“分析大型學術醫院系統的 COVID-19 反應和對婦科手術的影響”，許多患者在大流行期間轉向婦科手術。2020 年進行了 942 次婦科手術與 2019 年的 1,545 人相比（下降 39.0%）。 因此，預計 COVID-19 將對舉宮器設備市場產生重大影響。 然而，隨著 COVID-19 病例的減少，預計市場將在預測期內完全復甦。

推動所研究市場增長的因素包括與女性生殖系統相關的疾病負擔不斷增加、技術進步不斷增加以及對微創外科手術的需求不斷增加。 與女性生殖系統相關的常見疾病包括子宮內膜異位症、宮頸癌、子宮肌瘤、間質細胞病和多囊卵巢綜合徵。 根據世界衛生組織 (WHO) 2022 年 2 月更新，宮頸癌是全球女性第四大常見癌症，2020 年新增病例 604,000 例，死亡 34 例，估計為 2,000 例。 到 2020 年，全球約 90% 的新增病例和死亡病例將發生在低收入和中等收入國家。

根據 endometriosis.org 於 2021 年 3 月發表的一篇文章，據估計，子宮內膜異位症在生育期會影響十分之一的女性，通常年齡在 15 至 49 歲之間。全球約有 1.76 億女性。 因此，子宮內膜異位症的高患病率將增加對子宮切除手術的需求，從而增加對子宮機械手設備的需求並推動市場增長。

此外，確定子宮操縱器功效的研發程序將增加其採用率，從而促進市場的顯著增長。 例如，在 2020 年 12 月發表的“子宮操縱器在全腹腔鏡子宮切除術中的安全性和實用性”研究中，宮內操縱器可以在大子宮、嚴重子宮內膜異位症、直腸陰道粘連和局部麻醉的情況下提供支持。 因此，這些設備覆蓋範圍的擴大將提高它們的採用率並推動市場。 然而，在研究期間，對其中一些設備和產品批准的嚴格監管預計會限制市場增長。

舉宮器的市場趨勢

腹腔鏡子宮切除術部分預計在預測期內佔據最大的市場份額

全腹腔鏡子宮切除術 (TLH) 是一種通過四個小（1/2' 至 1'）腹部切口切除子宮和子宮頸的手術。 該手術還可能包括切除卵巢和輸卵管，具體取決於患者。 TLH 用於治療子宮疾病，例如子宮肌瘤、卵巢和陰道的盆腔疼痛感染以及異常陰道出血。

這些疾病負擔的增加和研發研究的增長等因素預計將推動市場的增長。 例如，根據 2021 年 8 月發表的一項題為“從工作台到床邊評估未滿足的需求的肌瘤”的研究結果，平滑肌腫瘤，有時也稱為子宮肌瘤，起源於子宮肌層，大約 30% 至 35% 的女性使用超聲波檢測確定患有肌瘤，預計美國 70% 以上的女性將在 50 歲時患上肌瘤。 此外，根據相同的數據，在美國，25% 患有子宮肌瘤的女性症狀嚴重到需要就醫。 因此，女性子宮肌瘤的高患病率有望推動市場發展，並增加宮腔鏡檢查程序和這些程序中使用的子宮操縱器。

此外，越來越多的研究表明在 TLH 手術期間使用舉宮器的有效性和安全性將提高其適用性，這也將有助於市場增長。 例如，根據研究“使用新設計的子宮操縱器（Halder's）進行全腹腔鏡子宮切除術”，“使用新設計的子宮操縱器（Halder's）進行全腹腔鏡子宮切除術：安全性、有效性、預防穿孔”，2020 年 4 月使用 Halders 子宮操縱器，它是執行 TLH 的簡單、智能和簡單的選擇，並發症更少，手術效果更佳。 這種操縱器可供沒有經驗的人在陰道內使用，這將對市場的增長產生積極影響。 2021 年 4 月發表的“腹腔鏡單點子宮切除術。文獻綜述和程序描述”研究表明，宮內操縱器可以更好地暴露骨盆區域，暴露手術野的正確手術平面，建議通過以下方式幫助外科醫生 因此，在 TLH 手術期間宮內操縱器的額外好處將推動市場增長。 因此，由於上述因素，該研究涵蓋的市場預計在研究期間將顯著增長。

預計在預測期內北美將佔據很大的市場份額

北美舉宮器市場增長的主要驅動力是宮頸癌和子宮內膜異位症等女性生殖系統疾病負擔的加重、微創手術需求的增加以及技術進步的不斷提高。

北美地區的美國對所研究市場的顯著增長做出了貢獻。 這些疾病在該國日益增加的負擔將提振市場。 例如，根據美國癌症協會 2022 年 1 月的更新，該國將在 2022 年診斷出約 14,100 例浸潤性宮頸癌新病例，估計有 4,280 名婦女死於該病。 因此，與宮頸癌相關的高患病率和高死亡率將促進其早期治療，從而增加對子宮機械手裝置的需求，因為它們用於對抗宮頸癌，從而推動市場，你將不得不推高。

此外，市場上研發研究的興起也將推動市場的增長。 例如，接受微創手術治療早期子宮癌的患者體內放置了舉宮器，而手術過程中獲得的液體中沒有放置舉宮器的患者體內有癌細胞。一項前瞻性、多中心、隨機、評估的非劣效性 3 期試驗將於 2021 年 5 月開始。 此類研究可以幫助評估子宮操縱器的有效性和安全性，並可以提高其適用性，從而促進市場增長。

在國家癌症中心2021年5月發表的論文《For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining》中，在微創手術中使用舉宮器，術者對子宮及周圍結構進行了提示提高訪問和可視化能力 因此，由於子宮操縱器在微創手術期間協助外科醫生，預計在研究期間對其的需求將增長，從而推動市場增長。 因此，由於上述因素，預計所研究的市場將在預測期內增長。

子宮操縱器設備市場競爭對手分析

由於存在多個市場參與者，子宮操縱器設備市場競爭適中。 市場上的主要參與者包括 Conkin Surgical Instrument Ltd.、CooperSurgical Inc.、B. Braun Melsungen AG、KARL STORZ GmbH & Co.KG、CONMED Corporation。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 與女性生殖系統相關的疾病負擔不斷增加
    • 技術進步和手術程序增多
  • 市場製約因素
    • 嚴格的產品審批規定
    • 手術費用高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 通過申請
    • 腹腔鏡全子宮切除術 (TLH)
    • 腹腔鏡宮頸內膜切除術 (LSH)
    • 腹腔鏡陰道子宮切除術 (LAVH)
    • 腹腔鏡宮頸切除術
    • 其他應用
  • 按產品類型
    • Dones 型子宮體操縱器
    • Tintara 型子宮體手術器械
    • Clermont-Ferrand 子宮切開術裝置
    • 霍爾型子宮體調節器
    • Advancula arch 型子宮輔助裝置
  • 最終用戶
    • 醫院
    • 婦科診所
    • 門診手術中心
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Conkin Surgical Instrument Ltd.
    • CooperSurgical Inc.
    • B. Braun Melsungen AG
    • KARL STORZ GmbH & Co. KG
    • CONMED Corporation
    • RUDOLF Medical GmbH+Co. KG
    • Richard Wolf GmbH
    • Utah Medical Products, Inc.
    • Purple Surgical
    • Clinical Innovations, LLC
    • Bissinger Medizintechnik
    • LSI Solutions, Inc.

第7章 市場機會與今後動向

簡介目錄
Product Code: 90491

The uterine manipulator devices market is expected to witness a CAGR of 5.8% during the study period, 2022-2027.

The COVID-19 pandemic was a challenge for healthcare providers across the world as due to the high infectivity of SARS-CoV-2, the resources were diverted for the care of COVID-19 patients which affected the healthcare services other than COVID-19 which also affected the uterine manipulator devices market. For instance, according to the research study published in October 2021, titled "Analysis of COVID-19 Response and Impact on Gynecologic Surgery at a Large Academic Hospital System", during the height of the pandemic, many patients had considerable delays in accessing gynecologic surgical care, and 942 gynecologic cases were performed in 2020 versus 1,545 cases in 2019 (a 39.0% drop). Hence, COVID-19 is expected to have a significant impact on the uterine manipulator devices market. However, with the declining cases of COVID-19, the market is expected to regain its full potential over the forecast period.

The factors propelling the studied market growth are the growing burden of diseases related to the female reproductive system, increasing technological advancements, and rising demand for minimally invasive surgical procedures. Common diseases related to the female reproductive system are endometriosis, cervical cancer, uterine fibroids, interstitial cytosis, and polycystic ovary syndrome, among others. According to February 2022 update by World Health Organization, cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020. About 90% of the new cases and deaths worldwide in 2020 occurred in low- and middle-income countries.

According to an article published by endometriosis.org in March 2021, endometriosis affects an estimated 1 in 10 women during their reproductive years, usually between the ages of 15 to 49, which is approximately 176 million women in the world. Thus, the high prevalence of endometriosis will increase the demand for hysterectomy procedures, thereby driving the demand for uterine manipulation devices, thus propelling the market growth.

Additionally, the research and development procedures establishing the efficacies of the intrauterine manipulator will increase its adoption, thereby contributing to the significant growth of the market. For instance, the study "Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness," published in December 2020, suggested that uterine manipulator provides support in cases of large uteri, severe endometriosis, recto vaginal adhesions, and regional anesthesia. Thus, the expanded scope of these devices will increase their adoptability, thus driving the market. However, some of these devices and stringent regulations regarding product approvals are expected to restrain the market growth during the study period.

Uterine Manipulation Devices Market Trends

Total Laparoscopic Hysterectomy Segment is Expected to Account for the Largest Market Share During the Forecast Period

Total Laparoscopic Hysterectomy (TLH) is the removal of the uterus and cervix through four small (1/2'- 1') abdominal incisions. This procedure may also include the removal of the ovaries and tubes, depending on the patient. TLH is performed to treat diseases of the uterus, such as fibroids, pelvic pain infection in ovaries and vaginal tubes, abnormal vaginal bleeding, and others.

The factors such as the growing burden of these diseases and growing research and development studies are expected to boost the market growth. For instance, according to the research study published in August 2021, titled "Uterine Fibroids: Assessing Unmet Needs from Bench to Bedside", smooth muscle tumors called leiomyomas, sometimes known as uterine fibroids, develop from the myometrium and using ultrasound detection, around 30%-35% of women will be identified as having fibroids, but it is predicted that more than 70% of women will do so by age 50 in the United States. Also, as per the same source, in the US, 25% of women with uterine fibroids will have symptoms bad enough to need medical attention. Hence, the high prevalence of fibroids among women is expected to increase the hysteroscopy procedures and uterine manipulators, as that is used in these procedures, thus driving the market.

Additionally, rising research studies proving the efficacy and safety of using uterine manipulators during TLH procedures will increase its adaptability, which will also contribute to market growth. For instance, according to the study "Total Laparoscopic Hysterectomy with a Newly Designed Uterine Manipulator (Halder's): Safety, Efficacy and Perforation Prevention" published in April 2020, the Halder's uterine manipulator is an easy, smart and simple option to do TLH, which reduces the complications and have more favorable operative outcomes. This manipulator can be used by inexperienced persons at the vaginal end, thus, positively impacting the market growth. The study "Laparoendoscopic Single Site Hysterectomy: Literature Review and Procedure Description," published in April 2021, suggests that intra-uterine manipulator permits a better exposure of the pelvic field, helping the surgeon by exposing the correct surgical planes of the operative field. Thus, added advantages of uterine manipulators during TLH procedures will fuel the market growth. Thus, owing to the above-mentioned factors, the studied market is expected to grow significantly during the study period.

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

The primary driving factors for the growth of the North American uterine manipulator market are the rising burden of female reproductive system diseases such as cervical cancer, endometriosis, and others, rising demand for minimally invasive surgeries, and rising technological advancements.

The United States within North America contributes to significant growth in the studied market. The rising burden of these diseases in the country will boost the market. For instance, according to a January 2022 update by the American Cancer Society, approximately 14,100 new cases of invasive cervical cancer will be diagnosed in 2022 in the country, with estimated 4,280 women deaths from the disease. Thus, the high prevalence and mortality rate associated with cervical cancer will boost its early treatment, thereby driving the demand for uterine manipulator devices as they are used for addressing cervical cancer, thus boosting the market.

The rising research and development studies in the market will also boost the market growth. For instance, a prospective, multicenter, randomized non-inferiority phase III study was initiated in May 2021 to evaluate if patients undergoing a minimally invasive surgery for early-stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed. Such studies will help in evaluating the efficacy and safety of uterine manipulators, which can boost their adaptability; therefore, such studies might contribute to market growth.

The article "For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining," published by National Cancer Institute in May 2021, suggested that uterine manipulators are used during minimally invasive procedures to improve the surgeon's ability to access and visualize the uterus and surrounding structures. Thus, as uterine manipulators assist surgeons during minimally invasive surgeries, the demand for the same is expected to grow during the study period, which will propel the market growth. Hence, owing to the above-mentioned factors, the studied market is expected to grow during the forecast period.

Uterine Manipulation Devices Market Competitor Analysis

The uterine manipulation devices market is moderately competitive owing to the presence of several market players. Some of the key players in the market are Conkin Surgical Instrument Ltd., CooperSurgical Inc., B. Braun Melsungen AG, KARL STORZ GmbH & Co. KG, CONMED Corporation, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Diseases Related to Female Reproductive System
    • 4.2.2 Technological Advancements and Rise in Surgical Procedures
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regualtions Regarding Product Approvals
    • 4.3.2 High Cost of Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Application
    • 5.1.1 Total Laparoscopy Hysterectomy (TLH)
    • 5.1.2 Laparoscopic Supracervical Hysterectomy (LSH)
    • 5.1.3 Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
    • 5.1.4 Sacrocolpopexy
    • 5.1.5 Other Applications
  • 5.2 By Product Type
    • 5.2.1 Donnez Type Uterine Manipulators
    • 5.2.2 Tintara Type Uterine Manipulators
    • 5.2.3 Clermont -Ferrand Type Uterine Manipulators
    • 5.2.4 Hohl Type Uterine Manipulators
    • 5.2.5 Advincula Arch Type Uterine Manipulators
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Specialized Gynecology Clinics
    • 5.3.3 Ambulatory Surgical Centers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Conkin Surgical Instrument Ltd.
    • 6.1.2 CooperSurgical Inc.
    • 6.1.3 B. Braun Melsungen AG
    • 6.1.4 KARL STORZ GmbH & Co. KG
    • 6.1.5 CONMED Corporation
    • 6.1.6 RUDOLF Medical GmbH + Co. KG
    • 6.1.7 Richard Wolf GmbH
    • 6.1.8 Utah Medical Products, Inc.
    • 6.1.9 Purple Surgical
    • 6.1.10 Clinical Innovations, LLC
    • 6.1.11 Bissinger Medizintechnik
    • 6.1.12 LSI Solutions, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS